![]() Music |
![]() Video |
![]() Movies |
![]() Chart |
![]() Show |
![]() |
Update on Long-acting Interferons for MPN (HMP Education) View |
![]() |
Development of long-acting interferon as new therapy for PV and ET (HMP Education) View |
![]() |
Long-acting interferon: What is the difference (HMP Education) View |
![]() |
The Future of Interferon in Myeloproliferative Neoplasms - Dr. JJ Kiladjian (MPN Education Foundation) View |
![]() |
10 facts MPN patients need to know about FDA approval of Ropegylated interferon alpha2b (Besremi). (UT Health San Antonio MD Anderson Cancer Center) View |
![]() |
Management of PV, The Role of Interferon (MPN Voice) View |
![]() |
Determining the Potential of Ropeginterferon Alfa-2b in Polycythemia Vera (OncLive) View |
![]() |
Updates in PV treatment: the efficacy of ropeginterferon alfa-2b (VJHemOnc β Video Journal of Hematology \u0026 HemOnc) View |
![]() |
4 Interferon Dr Martin Ellis (MPN Advocates Network) View |
![]() |
Indication for cytoreductive therapy in ET and PV: Do we have it right (HMP Education) View |